Biggest News Aggregation in the World
📰 Branded Generics News

Page 3 - Branded Generics News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Branded Generics. Real-time updates on events, politics, business and more.

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Ipca Laboratories share price: Buy Ipca Laboratories, target price Rs 2400: Motilal Oswal

Motilal Oswal has buy call on Ipca Laboratories Ltd. with a target price of Rs 2400. The current market price of Ipca Laboratories Ltd. is Rs 2066.05. Time period given by analyst is one year when Ipca Laboratories Ltd. price can reach defined target. Ipca Laboratories Ltd., incorporated in the year 1949, is a Mid Cap company (having a market cap of Rs 26410.61 Crore) operating in Pharmaceuticals sector. Financials For the quarter ended 31-03-2021, the company reported a Consolidated Total In...
Motilal Oswal Ipca Laboratories Ltd Ipca Laboratories Laboratories Ltd Mid Cap Consolidated Total Income

Broker's call: Ipca Lab (Buy) - The Hindu BusinessLine

CMP: ₹2,153.75 From our interaction with the management, we believe Ipca Laboratories (IPCA) has enough levers to outperform the market in Domestic Formulations (DF) and Branded Generics exports, with good visibility in the Institutional business and continued momentum in the API segment. IPCA has witnessed sustained growth momentum in the Pain segment. It has posted market share gains, on account of the pandemic, in products wherein smaller companies have been unable to meet supply requirem...
United Kingdom Motilal Oswal Ipca Laboratories Domestic Formulations Branded Generics Ipca Lab

Branded Generics Market is Projected to Grow Massively in Near Future – KSU

The  Branded Generics Market research report thoroughly explains each and every aspect related to the Global Branded Generics Market, which facilitates the report’s reader to study and evaluate the upcoming market trend and execute the analytical data to promote the business. Branded Generics Market Insight: Global Branded Generics Market is expected to rise from its initial estimated value of USD 232.83 billion in 2018 to a projected value of USD 421.15 billion by 2026, registering a CAGR...
United States Hong Kong United Kingdom South Africa Saudi Arabia Zydus Cadila

Nifty Pharma index surges 4%; Sun Pharma, Cipla hit 52-week highs

Shares of pharmaceutical companies were in focus at the bourses on Wednesday, with the Nifty Pharma surging 4 per cent after a consolidating in the last couple of days. Sun Pharmaceutical Industries and Cipla rallied 6 per cent each, hitting their respective 52-week highs on the National Stock Exchange (NSE) in intra-day trade. Torrent Pharmaceuticals and Dr Reddy’s Laboratories were up 5 per cent, while Divis Laboratories, Lupin, Cadila Healtchare and Biocon from the pharma index were up in ...
Nirmala Sitharaman Ajanta Pharma Cadila Healtchare Aatmanirbhar Swasth Bharat Yojana Torrent Pharmaceuticals Sun Pharmaceutical Industries

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science